{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:28:01Z","timestamp":1774510081680,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aims to characterize the clinical and genetic features of a sporadic case of dilated cardiomyopathy (DCM) associated with a TNNT2 variant and to review the variant spectrum of the TNNT2 gene in the Chinese DCM population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>A 41-year-old male proband diagnosed with DCM underwent comprehensive clinical evaluation. Whole-exome sequencing (WES) was performed on the proband to identify potential causative variants. Subsequently, Sanger sequencing was used to specifically validate the candidate TNNT2 variant in the proband and all available family members. Bioinformatic tools were employed to predict the pathogenicity of the identified variant, which was interpreted according to the American College of Medical Genetics and Genomics (ACMG) guidelines. A literature review of TNNT2 variants in Chinese DCM patients was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Clinical assessment revealed left ventricular dilation and systolic dysfunction in the proband. Genetic analysis identified a heterozygous missense variant in the TNNT2 gene (c.311G\u2009&amp;gt;\u2009A, p.Arg104His). Bioinformatic predictions consistently supported its deleterious effect and high conservation. The variant was not found in the available family members. Considering the maternal sudden death history, it is likely to be\n                      <jats:italic>de novo<\/jats:italic>\n                      or maternally inherited. Based on ACMG guidelines, the variant was classified as \u201cLikely Pathogenic\u201d. The literature review summarized 14 distinct TNNT2 variants from 20 reported Chinese DCM cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides a detailed clinical characterization of the TNNT2 c.311G\u2009&amp;gt;\u2009A (p.Arg104His) variant in a Chinese patient with sporadic DCM, contributing to the understanding of its phenotypic spectrum. The review provides an overview of the TNNT2 variant spectrum in the Chinese DCM population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1757484","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:19:19Z","timestamp":1774502359000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A TNNT2 variant in a sporadic case of dilated cardiomyopathy: a case report and review"],"prefix":"10.3389","volume":"13","author":[{"given":"Xinglin","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengjie","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingfeng","family":"Zha","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The diagnosis and evaluation of dilated cardiomyopathy","volume":"67","author":"Japp","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy\u2014a Heart Failure Society of America Practice Guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","article-title":"Atlas of the clinical genetics of human dilated cardiomyopathy","volume":"36","author":"Haas","year":"2015","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-med-052422-020535","article-title":"Genetics of dilated cardiomyopathy","volume":"75","author":"Eldemire","year":"2024","journal-title":"Annu Rev Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/eurjhf\/hfs191","article-title":"Gender-specific differences in major cardiac events and mortality in lamin A\/C mutation carriers","volume":"15","author":"van Rijsingen","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1093\/eurheartj\/ehab294","article-title":"Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction","volume":"42","author":"Verstraelen","year":"2021","journal-title":"Eur Heart J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","article-title":"Evidence-based assessment of genes in dilated cardiomyopathy","volume":"144","author":"Jordan","year":"2021","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/gim.2013.204","article-title":"The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing","volume":"16","author":"Pugh","year":"2014","journal-title":"Genet Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.119.037661","article-title":"Reevaluating the genetic contribution of monogenic dilated cardiomyopathy","volume":"141","author":"Mazzarotto","year":"2020","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.125.071523","article-title":"Disruption of cTnT-mediated sarcomere-mitochondrial communication results in dilated cardiomyopathy","volume":"152","author":"Ye","year":"2025","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"130ra47","DOI":"10.1126\/scitranslmed.3003552","article-title":"Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy","volume":"4","author":"Sun","year":"2012","journal-title":"Sci Transl Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.recesp.2015.06.028","article-title":"Clinical and prognostic profiles of cardiomyopathies caused by mutations in the troponin T gene","volume":"69","author":"Ripoll-Vera","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.ajhg.2023.08.003","article-title":"The penetrance of rare variants in cardiomyopathy-associated genes: a cross-sectional approach to estimating penetrance for secondary findings","volume":"110","author":"McGurk","year":"2023","journal-title":"Am J Hum Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","article-title":"Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy","volume":"332","author":"Watkins","year":"1995","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/CIRCGENETICS.111.959973","article-title":"Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene","volume":"5","author":"Pasquale","year":"2012","journal-title":"Circ: Cardiovasc Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8806","DOI":"10.1074\/jbc.274.13.8806","article-title":"Ca2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy","volume":"274","author":"Yanaga","year":"1999","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1006\/jmcc.2001.1473","article-title":"Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy","volume":"33","author":"Takahashi-Yanaga","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1073\/pnas.022628899","article-title":"Ca2+-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy","volume":"99","author":"Morimoto","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.yjmcc.2003.09.003","article-title":"Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization","volume":"35","author":"Lu","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.yjmcc.2020.10.006","article-title":"Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes","volume":"150","author":"Schuldt","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1016\/S0006-3495(01)75924-3","article-title":"Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region","volume":"81","author":"Palm","year":"2001","journal-title":"Biophys J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11115","DOI":"10.1073\/pnas.1710354114","article-title":"Molecular mechanisms and structural features of cardiomyopathy-causing troponin T mutants in the tropomyosin overlap region","volume":"114","author":"Gangadharan","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12864-025-11323-4","article-title":"Whole exome sequence reveals genetic profiles of primary cardiomyopathy and genotype-phenotype association in Chinese population","volume":"26","author":"Liu","year":"2025","journal-title":"BMC Genomics"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1757484\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:19:20Z","timestamp":1774502360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1757484\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":27,"alternative-id":["10.3389\/fcvm.2026.1757484"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1757484","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"article-number":"1757484"}}